• SENSEX
    NIFTY 50
Healthcare

True North to acquire 2.44 percent stake in Biocon Biologics for Rs 536.25 crore

Updated : January 07, 2020 09:13 AM IST

The transaction values Biocon Biologics at Rs 21,450 crore or around $3 billion, on a pre-money equity basis.
Post the completion of this transaction, Biocon will hold 96.07 percent stake in Biocon Biologics.
True North to acquire 2.44 percent stake in Biocon Biologics for Rs 536.25 crore

You May Also Like

Live TV
Advertisement